Study of interleukin-6 in the spread of colorectal cancer: The diagnostic significance of IL-6

Acta Medica Okayama

Volumn 60, Issue 6, 2006, Pages 325-330

  Ashizawa, Tatsuto ^a   Okada, Ryosuke ^a   Suzuki, Yoshiaki ^a   Takagi, Makoto ^a   Yamazaki, Tatsuyuki ^a   Sumi, Tetsuo ^a   Aoki, Toshiaki ^a   Aoki, Tatsuya ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Colorectal cancer; Diagnostic significance; Hepatic metastasis; IL 6; Lymph node metastasis

Indexed keywords

INTERLEUKIN 6; TUMOR MARKER;

ADULT; AGED; ARTICLE; COLORECTAL TUMOR; FEMALE; HUMAN; LIVER TUMOR; LYMPH NODE; MALE; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INTERLEUKIN-6; LIVER NEOPLASMS; LYMPH NODES; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 33846410675     PISSN: 0386300X     EISSN: 0386300X     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Tahara E: Growth factors and oncogenes in human gastrointestinal carcinomas. J Cancer Res Clin Oncol (1990) 116: 121-131.
2. Egami H, Kamohara H, Mita S and Ogawa M: Involvement of cytokines in invasion and metastasis of colon cancer. Nippon Geka Gakkai Zasshi (J Jpn Surg Soc) (1998) 99: 425-429 (in Japanese).
3. Hirano T and Kishimoto T: Interleukin-6; in Handbook of experimental pharmacology vol 95. Sporn MB ed, Springer-Verlag, Berlin (1990) pp 633-665.
4. Akira S, Taga T and Kishimoto T: Interleukin-6 in biology and medicine. Adv Immunol (1993) 54: 1-78.
5. Ueda T, Shimada E and Urakawa T: Serum levels of cytokines in patients with colorectal cancer: Possible involvement of intrleukin-6 and interleukin-8 in hematogenous metastasis. J Gastroenterol (1994) 29: 423-429.
6. Takeda K, Fujii N, Nitta Y, Sakihara H, Nakayama K, Rikiishi H and Kumagai K: Murine tumor cells metastasizing selectively in the liver: ability to produce hepatocyte-activating cytokines interleukin-1 and/or-6. Jpn J Cancer Res (1991) 82: 1299-1308.
7. Ashizawa T, Sumi T, Takagi M, Yamazaki T, Aoki T, Tomioka H, Maruyama S, Takimoto M, Aoki T and Koyanagi Y: The study of IL-6 in the spread of colorectal cancer -the role of IL-6 as a prognostic factor-. Jpn J Gastroenterol Surg (2004) 37: 656-662 (in Japanese).
8. General Rules for Clinical and Pathological Studies on Cancer of the Colon, Rectum and Anus: Japanese Society for Cancer o the Colon and Rectum. 7 th Ed, Kanehara, Tokyo (2006).
9. Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T, Kashiwamura S, Nakajima K, Koyama K, Iwamatsu A, Tsunasawa A, Sakiyama F, Matsui H, Takahara Y, Taniguchi T and Kishimoto T: Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature (1986) 324: 73-76.
10. Zilberstein A, Ruggieri R, Korn JH and Revel M: Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth-stimulatory cytokines. EMB0J (1986) 5: 2529-2537.
11. Haegeman G, Content J, Volckaert G, Derynck R, Tavernier J and Fires W: Structural analysis of the sequence coding for an inducible 26-kDa protein in human fibroblasts. Eur J Biochem (1986) 159: 625-632.
12. Hibi M, Murakami M, Saito M, Hirano T, Taga T and Kishimoto T: Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell (1990) 63: 1149-1157.
13. Fidler IJ: Selection of successive tumour lines for metastasis. Nat New Biol (1973) 242: 148-149.
14. Tamm I, Cardinale I and Sehgal PB: Interleukin-6 and 12-O-tetradecanoyl phorbol-13-acetate act synergistically in inducing cell-cell separation and migration of human breast carcinoma cells. Cytokine (1991) 3: 212-223.
15. Kitamura N, Miyazawa K, Uehara Y, Komada M, Okajima A, Okigaki M and Kitamura A: Gene expression and regulation of HGF-SF. EXS (1993) 65: 49-65.
16. Liu Y, Tolbert EM, Sun AM and Dworkin LD: Primary structure of rat HGF receptor and induced expression in glomerular mesangial cells. Am J Physiol (1996) 27: F679-688.
17. Ashizawa T, Aoki T, Sumi T, Katsumata K, Tomioka H, Koyanagi Y and Yamamoto K: The study of hepatocyte growth factor (HGF) in the spreading of colorectal cancer -the clinical role of HGF in Dukes' classification-. Jpn J Gastroenterol Surg (2002) 35: 480-486 (in Japanese).
18. Gherardi E and Stoker M: Hepatocyte growth factor-scatter factor: mitogn, motogen and met. Cancer Cells (1991) 3: 227-232.
19. Rubin JS, Chan AM, Bottaro DP, Burgess WH, Taylor WG, Cech AC, Hirschfield DW, Wong J, Miki T, Finch PW and Aaronson SA: A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. Proc Natl Acad Sci USA (1991) 88: 415-419.
20. Shalaby MR, Waage A, Aarden L and Espevik T: Endotoxin, tumor necrosis factor-α and interleukin 1 induce interleukin 6 production in vivo. Clin Immunol Immunopathol (1989) 53: 488-498.
21. Fong Y, Tracy KJ, Moldawer LL, Hesse DG, Manogue KB, Kenney JS, Lee AT, Kuo GC, Allison AC, Lowry SF and Cerami A: Antibodies to cachectin/tumor necrosis factor reduce interleukin 1β and interleukin 6 appearance during lethal bacteremia. J Exp Med (1989) 170: 1627-1633.
22. Gangopadhyay A, Lazure DA and Thomas P: Adhesion of colorectal carcinoma cells to the endothelium is mediated by cytokines from CEA stimulated Kupffer cells. Clin Exp Metastasis (1998) 16: 703-712.
23. Edmiston KH, Gangopadhyay A, Shoji Y, Nachman AP, Thomas P and Jessup JM: In vivo induction of murine cytokine production by carcinoembryonic antigen. Cancer Res (1997) 57: 4432-4436.
24. Belluco C, Nitti D, Frantz M, Toppan P, Basso D, Plebani M, Lise M and Jessup JM: Interleukin-6 blood level is associated with circulating carcinoembryonic antigen and prognosis in patients with colorectal cancer. Ann Surg Oncol (2000) 7: 133-138.
25. Metz CE, Herman BA and Shen J-H: Maximum likelihood estimation of receiver operating characteristic (ROC) curves from continuously-distributed data. Statist Med (1998) 17: 1033-1053.
26. Dorfman DD and Alf E Jr: Maximum likelihood estimation of parameters of signal-detection theory and determination of confidence intervals-rating-method data. J Math Psych (1969) 6: 487-496.
27. Takahashi Y: Gastrointestinal tract; in Tumor marker clinical manual, Ookura H ed, Igaku-shoin, Tokyo (1999) pp 80-83 (in Japanese).
28. 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA (1987) 84: 7251-7255.
29. Nijsten MWN, de Groot ER, ten Duis HJ, Klasen HJ, Hack CE and Aarden LA: Serum levels of interleukin-6 and acute phase responses. Lancet (1987) 2: 921.